We use cookies to customize content for your viewing and for analytics. If you continue to browse this website, we will assume that you are happy to receive all our cookies. For further information please read our cookie policy.
Cartiva
Synthetic Cartilage Implant
The Cartiva SCI is a novel osteochondral defect repair implant with properties similar to those of cartilage, designed for the treatment of first metatarsophalangeal joint osteoarthritis.
Setting a new standard for treating hallux rididus
Proven effective in the largest, longest multi-center trial ever conducted for first MTP OA.1
Study data evaluated as low risk of bias in comprehensive published review.2
Awarded the Roger A. Mann Award twice (2015 & 2017), for the best clinical research in foot and ankle.1,3
References
- Baumhauer JF, Singh D, Glazebrook M, et al. Foot Ankle Int. 2016;37(5):457-469; N=130 in CARTIVA pivotal trial cohort.
- Stevens J, de Bot RT, Hermus JP, et al. JBJS reviews 5.11 (2017): e2.
- Baumhauer JF, Singh D, Glazebrook M, et al. Foot Ankle Int. 2017 Nov;38(11):1175-1182.
AP-015716